Literature DB >> 6211313

Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome.

R M Victorino, P Ryan, G R Hughes, H J Hodgson.   

Abstract

Lymphocyte responsiveness to mitogens (phytohaemagglutinin (PHA), concanavalin A (Con A), and pokeweed mitogen (PWM)), T-cell subsets (T mu and T gamma) and short-lived suppressor cell activity were investigated in the peripheral blood of seven patients with Behçet's syndrome and compared to normal individuals and patients with systemic lupus erythematosus (SLE). Amongst patients with Behçet's syndrome, responses to mitogens PHA and Con A were normal or slightly reduced; numbers of circulating T gamma cells were unaltered whereas T mu cells were reduced (P less than 0 . 05) compared with normal individuals. This was in contrast to SLE where a marked reduction in responses to PHA and Con A was found with reduced T gamma cell but normal T mu cell numbers. Although the mean suppressor cell activity in the Behçet's group was significantly reduced, all patients had values within the normal range, in contrast with SLE where the reduction was much more marked and most patients had values below the normal range. In conclusion, the pattern of alteration in T mu and T gamma cells in Behçet's syndrome is distinct from that in SLE, and the reduction of short-lived suppressor cell activity is only mild in Behçet's syndrome but marked in SLE.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6211313      PMCID: PMC1536574     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

2.  Lymphocytotoxicity in recurrent aphthous stomatitis. Lymphocytotoxicity for oral epithelial cells in recurrent aphthous stomatitis and Bechet syndrome.

Authors:  R S Rogers; W M Sams; R G Shorter
Journal:  Arch Dermatol       Date:  1974-03

3.  Characterization of mucosal antibodies in recurrent aphthous ulceration and Behcet's syndrome.

Authors:  T Lehner
Journal:  Arch Oral Biol       Date:  1969-07       Impact factor: 2.633

4.  Subpopulations of human T lymphocytes. I. Studies in immunodeficient patients.

Authors:  S Gupta; R A Good
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

Review 5.  Suppressor cells in the regulation of the immune response.

Authors:  T A Waldmann; S Broder
Journal:  Prog Clin Immunol       Date:  1977

6.  Behçet's syndrome and autoimmunity.

Authors:  T Lehner
Journal:  Br Med J       Date:  1967-02-25

7.  Immune complexes in Behçet's syndrome and recurrent oral ulceration.

Authors:  B D Williams; T Lehner
Journal:  Br Med J       Date:  1977-05-28

8.  Behçet's disease: possible role of secretory component deficiency, synovial inclusions, and fibrinolytic abnormality in the various manifestations of the disease.

Authors:  N I Abdou; H R Schumacher; R W Colman; A Sagawa; J Hebert; E Pascual; E T Carroll; M Miller; M A South; N L Abdou
Journal:  J Lab Clin Med       Date:  1978-03

9.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  8 in total

1.  Behçet's disease with a large intracardiac thrombus: a case report.

Authors:  M Baykan; S Celik; C Erdöl; E C Baykan; I Durmus; S Bahadir; H Erdöl; C Orem; H Cakirbay
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

2.  The relationship between HRCT and pulmonary function in Behcet's disease.

Authors:  H Uysal; S Balevi; N Okudan; H Gökbel
Journal:  Lung       Date:  2004       Impact factor: 2.584

3.  The expression of gamma delta T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behçet's syndrome.

Authors:  F Fortune; J Walker; T Lehner
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

4.  A defect in immunoregulatory synovial fluid T cells in Behçet's syndrome.

Authors:  J Alcocer-Varela; A Laffon; C Abud-Mendoza; D Alarcon-Segovia
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

5.  Thalidomide and cell mediated immunity in Behçet's disease.

Authors:  M Hamza; K Hamzaoui; K Ayed; M Eleuch; A Zribi
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

6.  Natural killer cells in Behçet's disease.

Authors:  K Hamzaoui; K Ayed; M Hamza; J L Touraine
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

7.  Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies.

Authors:  G Valesini; P Pivetti-Pezzi; F Mastrandrea; A Moncada; M Cuomo; P G Natali
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

8.  CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease.

Authors:  C Young; T Lehner; C G Barnes
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.